WSJ
13 Oct 2026, 08:28 UTC · 1h ago
Impact · against what's priced in
Givaudan's 11% sales growth beat expectations, likely leading to upward revisions for FY2026 EPS estimates. This represents a positive surprise that provides immediate upward momentum for the stock.
Scored by the NIS engine · methodology.
Search tags
What the story claims
1 claim · scored −1 bearish … +1 bullish · 0 new · 1 priced in
Givaudan's sales rose 11% compared with the year-earlier period, beating expectations.
Priced inshares were already up more than 6%
So whatThe positive surprise likely triggers upward revisions to FY2026 EPS estimates.
More positive than 93% of claims this week
Continue reading
5 related stories
Read next
Proactive Investors · 2h ago
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
Zacks Investment Research
27m ago
